Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tuberous Sclerosis 1 Psychological Well-Being 1 Pain 1 Neoplasms 1 Hematopoietic Cell Transplantation Recipient 1 Depression 1 Breast Cancer Female 1 Brain Neoplasms 1

Interventions

Radiosurgery 12 Temozolomide 10 Radiotherapy 10 Magnetic Resonance Spectroscopy 7 Erlotinib Hydrochloride 6 Bevacizumab 6 Surgical Procedures, Operative 5 Pemetrexed 5 Gefitinib 5 Drug Therapy 5 Carboplatin 5 pyrotinib 4 icotinib 4 aumolertinib 4 Trastuzumab 3 Spermine Synthase 3 Radiation 3 Lomustine 3 Etoposide 3 Dexmedetomidine 3 Chlorotoxin 3 Carmustine 3 osimertinib 2 camrelizumab 2 apatinib 2 Tyrosine Kinase Inhibitors 2 Thiotepa 2 Surveys and Questionnaires 2 Sevoflurane 2 Propofol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Brain Neoplasms × Acceptance and Commitment Therapy × Clear all

NCT04722237 2023-08-31

ACT NOW

Nottingham University Hospitals NHS Trust

Phase NA Unknown

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡